Market Overview
The global Infection Surveillance Solutions market size was valued at USD 577 million in 2022 and is projected to reach USD 1,500 million by 2033, growing at a CAGR of 13.4% during the forecast period.

Report Scope

Report Attributes	Description
Market Forecast in 2022	USD 577 million
Market Forecast in 2033	USD 1,500 million
CAGR % 2023-2033	13.4%
Base Year	2022
Historic Data	2020-2021
Forecast Period	2023-2033
Report USP	Product, end-user industry, company share, company heat map, company Capacity Technology Product capacity, growth factors and more
Key Companies	Becton, Dickinson and Company (BD); Thermo Fisher Scientific Inc.; Wolters Kluwer N.V.; Baxter International Inc.; Roche Diagnostics; Bio-Rad Laboratories, Inc.; Johnson & Johnson; Cepheid Inc. (a Danaher Corporation company); 3M Company; Hologic, Inc.

Global Infection Surveillance Solutions Market- Description
The Infection Surveillance Solutions Market refers to the market for software and systems that help in monitoring and preventing the spread of infections in healthcare settings. These solutions play a crucial role in identifying and controlling healthcare-associated infections (HAIs) and other infectious diseases. The primary objective of infection surveillance solutions is to track and analyze data related to infections in healthcare facilities, including hospitals, clinics, nursing homes, and other healthcare settings. These solutions collect and analyze various types of data, such as patient information, laboratory results, and clinical observations, to identify patterns and trends related to infections. With the rise in healthcare-associated infections and the emergence of antibiotic-resistant strains of bacteria, there is a growing emphasis on infection control measures. Infection surveillance solutions provide real-time data on infection rates, allowing healthcare facilities to implement effective prevention and control strategies. Infection surveillance solutions are incorporating advanced analytics and AI technologies to analyze large volumes of data and identify potential outbreaks or patterns of infections. These technologies enable healthcare facilities to proactively detect and respond to infections, leading to improved patient outcomes. Integration with EHRs and other healthcare systems allows infection surveillance solutions to access comprehensive patient information and laboratory data, facilitating more accurate surveillance and reporting. This integration streamlines workflow and enhances the effectiveness of infection control efforts.

Global Infection Surveillance Solutions market: Key Trends
• Mobile and cloud-based solutions
The availability of mobile and cloud-based infection surveillance solutions allows for real-time data collection, analysis, and reporting from various healthcare settings. These solutions provide flexibility, accessibility, and scalability, enabling healthcare facilities to monitor and manage infections efficiently. Infection surveillance solutions are increasingly focusing on interoperability and seamless data exchange with other healthcare systems, such as laboratory information systems and public health agencies. This interoperability facilitates coordinated efforts in monitoring and responding to infectious disease outbreaks.

• Expansion of the market beyond hospitals
The scope of infection surveillance solutions is expanding beyond hospitals to include other healthcare settings, such as long-term care facilities, ambulatory care centers, and outpatient clinics. This expansion is driven by the recognition that infections can occur in various healthcare settings, and proactive surveillance is necessary to prevent their spread.

Global Infection Surveillance Solutions market: Segmental Analysis
Software
• On-Premise
• Web-Based

End User
• Hospitals
• Long-Term Care Facilities

Global Infection Surveillance Solutions market: Geographical landscape
The infection surveillance solutions market has witnessed significant growth in recent years due to the increasing focus on healthcare-associated infections (HAIs) and the need for effective infection control measures. Regional analysis of the market provides insights into the adoption and growth of these solutions in different geographical areas. North America is a major market for infection surveillance solutions, primarily driven by the presence of well-established healthcare infrastructure and stringent infection control regulations. The United States dominates the market in this region, with a high adoption rate of infection surveillance solutions in healthcare facilities. The growing emphasis on reducing HAIs, rising healthcare expenditure, and the presence of key market players contribute to market growth in this region.

Global Infection Surveillance Solutions Market- Impact of COVID-19
The outbreak of COVID-19 has led to a heightened awareness and focus on infection control and prevention. As a result, there has been a surge in demand for infection surveillance solutions to monitor and manage the spread of the virus within healthcare facilities and other settings. This increased demand has positively impacted the market. To address the challenges posed by the pandemic, healthcare facilities and organizations have accelerated their adoption of digital technologies, including infection surveillance solutions. These solutions enable real-time monitoring, data analysis, and reporting, which are crucial in tracking and managing infections effectively. The need to strengthen healthcare infrastructure to cope with the pandemic has resulted in the establishment of temporary healthcare facilities, field hospitals, and additional testing centers. Infection surveillance solutions have played a vital role in monitoring and controlling the spread of infections in these settings.

Global Infection Surveillance Solutions Market: Key Companies
• Becton, Dickinson and Company (BD)
• Thermo Fisher Scientific Inc.
• Wolters Kluwer N.V.
• Baxter International Inc.
• Roche Diagnostics
• Bio-Rad Laboratories, Inc.
• Johnson & Johnson
• Cepheid Inc. (a Danaher Corporation company)
• 3M Company
• Hologic, Inc.
• Others

Global Infection Surveillance Solutions Market: Regional Scope
North America
• U.S.
• Canada
• Mexico

Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific

South America
• Brazil
• Argentina
• Rest of South America

Middle East and Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of Middle East and Africa

Why to buy this Report?
The report provides quantitative and qualitative aspect for the market in terms of value and volume, along with supporting market trends, challenges, restraints.

The report provides an in depth analysis from both production and consumption point of view at the regional and country level. Key Factors considered within the report scope are Production capacity by countries/regions, average price, consumption ratio, revenue earned and gross margin.

The report provides competitive analysis of around 30-50 companies operated in the market, these companies are bifurcated into niche players, the leaders and major contenders. The companies are analyzed in terms of following factors such as:
• Business Model
• Production Capacity, Revenue, Sales, Gross Margin
• Key Business Strategy
• SWOT Analysis

In terms of competitive landscape, the report provides distinctive factors that would help the end user in taking a key decision within the business:
• Company Share Analysis from 2018-2022
• Company Analysis by Revenue and Sales
• Company Production Capacity, Gross Margin
• Company Share Analysis by Application/End Use
• Company Share Analysis by Product/Specification.

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?